BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 11789027)

  • 1. 99mTc-Tetrofosmin pinhole-SPECT (P-SPECT) and radioguided sentinel node (SN) biopsy and in breast cancer axillary lymph node staging.
    Spanu A; Dettori G; Chessa F; Porcu A; Cottu P; Solinas P; Falchi A; Solinas ME; Scanu AM; Nuvoli S; Madeddu G
    Cancer Biother Radiopharm; 2001 Dec; 16(6):501-13. PubMed ID: 11789027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of (99m)Tc-tetrofosmin pinhole-SPECT in breast cancer non palpable axillary lymph node metastases detection.
    Spanu A; Tanda F; Dettori G; Manca A; Chessa F; Porcu A; Falchi A; Nuvoli S; Madeddu G
    Q J Nucl Med; 2003 Jun; 47(2):116-28. PubMed ID: 12865872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of tomographic nuclear medicine procedures, SPECT and pinhole SPECT, with cationic lipophilic radiotracers for the evaluation of axillary lymph node status in breast cancer patients.
    Madeddu G; Spanu A
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S23-34. PubMed ID: 15085293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different biological and prognostic breast cancer populations identified by FDG-PET in sentinel node-positive patients: results and clinical implications after eight-years follow-up.
    Agresti R; Crippa F; Sandri M; Martelli G; Tagliabue E; Alessi A; Pellitteri C; Maccauro M; Maugeri I; Barbara P; Rampa M; Moscaroli A; Ferraris C; Carcangiu ML; Bianchi G; Greco M; Bombardieri E
    Breast; 2014 Aug; 23(4):334-40. PubMed ID: 24485802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer?
    Brenot-Rossi I; Houvenaeghel G; Jacquemier J; Bardou VJ; Martino M; Hassan-Sebbag N; Pasquier J
    J Nucl Med; 2003 Aug; 44(8):1232-7. PubMed ID: 12902412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative dynamic lymphoscintigraphy predicts sentinel lymph node metastasis in patients with early breast cancer.
    Nakashima K; Kurebayashi J; Sonoo H; Tanaka K; Ikeda M; Shiiki S; Yamamoto Y; Nomura T; Sohda M; Seki M; Miyake A; Moriya T; Sadahira Y; Mimura H; Fukunaga M
    Breast Cancer; 2010; 17(1):17-21. PubMed ID: 19466508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accurate staging with internal mammary chain sentinel node biopsy for breast cancer.
    Gnerlich JL; Barreto-Andrade JC; Czechura T; John JR; Turk MA; Kennedy TJ; Winchester DJ
    Ann Surg Oncol; 2014 Feb; 21(2):368-74. PubMed ID: 24046119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the Accuracy of Axillary Lymph Node Surgery in Breast Cancer with Ultrasound-Guided Wire Localization of Biopsy Proven Metastatic Lymph Nodes.
    Plecha D; Bai S; Patterson H; Thompson C; Shenk R
    Ann Surg Oncol; 2015 Dec; 22(13):4241-6. PubMed ID: 25814365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of 99mTc-tetrofosmin Pinhole-SPECT in breast cancer axillary lymph node staging.
    Spanu A; Dettori G; Chiaramida P; Cottu P; Falchi A; Porcu A; Solinas ME; Nuvoli S; Madeddu G
    Cancer Biother Radiopharm; 2000 Feb; 15(1):81-91. PubMed ID: 10740656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of axillary ultrasound (AUS) on axillary dissection in breast conserving surgery (BCS).
    Reyna C; Kiluk JV; Frelick A; Khakpour N; Laronga C; Lee MC
    J Surg Oncol; 2015 Jun; 111(7):813-8. PubMed ID: 25753101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (99)mTc-tetrofosmin SPET in the detection of both primary breast cancer and axillary lymph node metastasis.
    Spanu A; Dettori G; Nuvoli S; Porcu A; Falchi A; Cottu P; Solinas ME; Scanu AM; Chessa F; Madeddu G
    Eur J Nucl Med; 2001 Dec; 28(12):1781-94. PubMed ID: 11734916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of the lymphoscintigraphy in the evaluation of non-axillary sentinel lymph node localization in breast cancer.
    Gherghe M; Bordea C; Blidaru A
    Chirurgia (Bucur); 2015; 110(1):26-32. PubMed ID: 25800312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraoperative localization of the sentinel node in breast cancer: technical aspects of lymphoscintigraphic methods.
    De Cicco C; Chinol M; Paganelli G
    Semin Surg Oncol; 1998 Dec; 15(4):268-71. PubMed ID: 9829385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of sentinel lymph node in patients with early stage breast cancer].
    Tang J; Yang MT; Fan W; Wang X; Zhang X; Liang XM; Wang X; Xie ZM
    Ai Zheng; 2005 Sep; 24(9):1111-4. PubMed ID: 16159435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma.
    Boolbol SK; Fey JV; Borgen PI; Heerdt AS; Montgomery LL; Paglia M; Petrek JA; Cody HS; Van Zee KJ
    Ann Surg Oncol; 2001; 8(1):20-4. PubMed ID: 11206219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined radioguided nonpalpable lesion localization and sentinel lymph node biopsy for early breast carcinoma.
    Barros AC; Barros MA; Andrade FE; Mori LJ; Costa PA; Sheng PY; Pelizon CH
    Ann Surg Oncol; 2007 Apr; 14(4):1472-7. PubMed ID: 17225979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sentinel node biopsy in T2 breast cancers larger than 3 cm and clinically negative axilla compared with the T1-T2 <3 cm standard indication].
    Ruano R; Ramos M; García-Talavera JR; García Macías MC; Martín de Arriba A; González-Orús JM; Iglesias M; Serrano E
    Rev Esp Med Nucl; 2008; 27(3):176-82. PubMed ID: 18570859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Presence of intramammary lymph nodes in the preoperative lymphoscintigraphy to locate the sentinel lymph node. Clinical significance].
    Nogareda Z; Álvarez A; Perlaza P; Caparrós FX; Alonso I; Paredes P; Vidal-Sicart S
    Rev Esp Med Nucl Imagen Mol; 2015; 34(2):83-8. PubMed ID: 25434980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE;
    Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.